Evolv Technologies Holdings, Inc.·4

Jun 22, 4:05 PM ET

Charlton Kevin M. 4

Research Summary

AI-generated summary

Updated

Evolv (EVLV) Director Kevin Charlton Exercises Derivatives & Receives RSUs

What Happened

  • Director Kevin M. Charlton reported a conversion/exercise of derivative instruments for 27,050 shares on June 17, 2026 (transaction code M) and a separate grant/award of 28,318 Restricted Stock Units (RSUs) on June 18, 2026 (transaction code A). Both transactions are reported at $0.00 per share, so the filing shows no cash paid or received and reports $0 total value for the items disclosed.
  • The 27,050-share transaction shows both an acquisition and a disposition of the derivative on June 17 (reported at $0). The June 18 entry is an acquisition of 28,318 RSUs (contingent rights to receive Class A shares).

Key Details

  • Transaction dates: 2026-06-17 (exercise/conversion of 27,050); 2026-06-18 (grant of 28,318 RSUs).
  • Reported price: $0.00 for all reported items; reported $0 total value.
  • Shares owned after transaction: Not specified in the filing.
  • Footnotes: F1—Each RSU equals a contingent right to one Class A share; no expiration. F2—Some RSUs vested in full on June 17, 2026. F3—The newly reported RSUs will vest in full at the earlier of June 18, 2027 or the day before the issuer’s next annual meeting.
  • Filing timeliness: Report filed 2026-06-22 for a 2026-06-17 transaction (filed 5 days after the transaction date), which appears later than the standard 2-business-day Form 4 filing window.

Context

  • Derivative code M indicates an exercise or conversion of a derivative instrument; here that conversion was reported at $0 and included a simultaneous disposition entry on the same day. The A entries are RSU grants—these are awards that convert into shares only upon vesting, so they are not immediate open-market purchases. These filings are factual disclosures of insider activity and do not, by themselves, indicate the director’s motivation.